Abstract
ObjectivesExamine whether data from early access to medicines in the USA can be used to inform National Institute for Health and Care Excellence (NICE) health technology assessments (HTA) in oncology.DesignRetrospective...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have